ClassID:

96736

C07K7/06 - page 10 - CPC Classification

Classification description:

Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids

Recent Application in this class:
#2701
20170042960
2017-02-16

Compositions and methods for treating hepatitis B

#2702
20170037154
2017-02-09

Composition comprising branched multipeptide vaccine and vaccine comprising the same

#2703
20170037111
2017-02-09

Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2704
20170037110
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2705
20170037107
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2706
20170037098
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2707
20170037097
2017-02-09

Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers

#2708
20170037096
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2709
20170037095
2017-02-09

Method for treating cancer with an activated T lymphocyte that selectively recognizes a cancer cell consisting of specific peptide

#2710
20170037094
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2711
20170037093
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2712
20170037092
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2713
20170037085
2017-02-09

Peptidomimetic compounds

#2714
20170037084
2017-02-09

Macrocyclic peptidomimetics for alpha-helix mimicry

#2715
20170035906
2017-02-09

(Anti-HER2 antibody)-drug conjugate

#2716
20170035807
2017-02-09

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#2717
20170029842
2017-02-02

Modified plant defensins useful as anti-pathogenic agents

#2718
20170029812
2017-02-02

GENETICALLY ENGINEERED POLYMER LIBRARIES AND METHODS OF USING THEM

#2719
20170029504
2017-02-02

Anti-PVRIG antibodies and methods of use

#2720
20170029483
2017-02-02

Murine anti-NY-ESO-1 T cell receptors

#2721
20170029464
2017-02-02

Viral vector for the targeted transfer of genes in the brain and spinal cord

#2722
20170029463
2017-02-02

SAA-domain-specific antibodies and peptide antagonists and use thereof to treat inflammatory diseases

#2723
20170028041
2017-02-02

HLA-A2 tumor associated antigen peptides and compositions

#2724
20170022251
2017-01-26

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

#2725
20170020956
2017-01-26

Peptides having anti-inflammatory properties

#2726
20170015991
2017-01-19

Hybrid polymers, pharmaceutical compositions and methods of synthesizing the same

#2727
20170015885
2017-01-19

Protein-based adhesives

#2728
20170015708
2017-01-19

CHEMOKINE BINDING POLYPEPTIDES FOR TREATING AUTOIMMUNITY, AND INFLAMMATION

#2729
20170014495
2017-01-19

ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF

#2730
20170008939
2017-01-12

Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain

#2731
20170008928
2017-01-12

NOVEL PEPTIDES AND PEPTIDE DERIVATIVES AND USES THEREOF

#2732
20170008927
2017-01-12

ARTIFICIAL CATALYST SYSTEM SUBSTITUTABLE FOR IN VIVO ACYLATION FUNCTION

#2733
20170008926
2017-01-12

Rare earth material-binding peptide and use thereof

#2734
20170008925
2017-01-12

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#2735
20170008922
2017-01-12

Branched chain-containing aromatic compound

#2736
20170007696
2017-01-12

Supramolecular hydrogel of fMLF-based molecules and use thereof

#2737
20170002057
2017-01-05

COMPOSITIONS CONTAINING FUSION PROTEIN OF ALBUMIN AND ANALOGS THEREOF, METHODS FOR MAKING AND USING THE SAME

#2738
20170002055
2017-01-05

Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2739
20170002050
2017-01-05

EphA2 T-cell epitope agonists and uses therefore

#2740
20170002047
2017-01-05

Plant-derived elastin binding protein ligands and methods of using the same

#2741
20170002043
2017-01-05

Peptides and methods and uses thereof for preventing retinal disorders

#2742
20170002042
2017-01-05

Peptidomimetic macrocycles

#2743
20170002041
2017-01-05

NOVEL ULTRASHORT HYDROPHOBIC PEPTIDES THAT SELF-ASSEMBLE INTO NANOFIBROUS HYDROGELS AND THEIR USES

#2744
20160376354
2016-12-29

Human islet amyloid polypeptide (HIAPP) specific antibodies and uses thereof

#2745
20160376346
2016-12-29

Fc fusion proteins comprising novel linkers or arrangements

#2746
20160376335
2016-12-29

POLYMERS CONTAINING MULTIVALENT AMYLOID-BETA-BINDING D-PEPTIDES AND THEIR USE

#2747
20160376318
2016-12-29

POLYPEPTIDE, DNA MOLECULE ENCODING THE POLYPEPTIDE, VECTOR, PREPARATION METHOD AND USE

#2748
20160376317
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

#2749
20160376316
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

#2750
20160376315
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

#2751
20160376314
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

#2752
20160376313
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

#2753
20160376312
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

#2754
20160376311
2016-12-29

Peptoids and methods for treating Alzheimer's disease

#2755
20160376310
2016-12-29

Peptide domains that bind small molecules

#2756
20160376308
2016-12-29

Synthetic peptide amides and dimers thereof

#2757
20160375177
2016-12-29

Self-assembling peptides, peptidomimetics and peptidic conjugates as building blocks for biofabrication and printing

#2758
20160369247
2016-12-22

Substrate-mimetic AKT inhibitor

#2759
20160368976
2016-12-22

Methods for treating pain using antibodies to Kallidin and des-Arg-Kallidin

#2760
20160368962
2016-12-22

Melanocortin Receptor Ligands

#2761
20160368958
2016-12-22

HJURP peptides and vaccines including the same

#2762
20160368950
2016-12-22

Immunogenic compositions and methods

#2763
20160367649
2016-12-22

CANCER VACCINE COMPOSITION

#2764
20160367628
2016-12-22

Molecular marker for cancer stem cell

#2765
20160362466
2016-12-15

Peptides having osteoblast growth-promoting activity and use thereof

#2766
20160362465
2016-12-15

WT1 antigenic polypeptide, and anti-tumor agent containing said polypeptide

#2767
20160362445
2016-12-15

Solid phase peptide synthesis via side chain attachment

#2768
20160362439
2016-12-15

Cyclic peroxides as prodrugs for selective delivery of agents

#2769
20160361434
2016-12-15

mTG substrates for covalent conjugation of compounds

#2770
20160361378
2016-12-15

Bifunctional compounds for relief of pain comprising an opioid receptor agonist moiety and a NK1 receptor antagonist moiety and methods for treating pain

#2771
20160356723
2016-12-08

Light-Up Probes Based On Fluorogens With Aggregation Induced Emission Characteristics For Cellular Imaging And Drug Screening

#2772
20160355555
2016-12-08

Mimotopes of tropomyosin for use in immunotherapy for shellfish and/or arthropod allergy

#2773
20160355551
2016-12-08

Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress syndrome

#2774
20160355550
2016-12-08

Immunotherapy against several tumors including neuronal and brain tumors

#2775
20160355549
2016-12-08

Peptide having activity of inhibiting production of toxin by bacterium belonging to genus clostridium

#2776
20160355548
2016-12-08

Tumor-targeting polypeptide and application thereof

#2777
20160354480
2016-12-08

Activated neurotensin molecules and the uses thereof

#2778
20160354428
2016-12-08

Methods and compositions related to inhibition of viral entry

#2779
20160354409
2016-12-08

MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

#2780
20160347794
2016-12-01

ANG-(1-7) derivative oligopeptides and methods for using and producing the same

#2781
20160346421
2016-12-01

Aptamer-modified polymeric materials for the binding of factors in a wound environment

#2782
20160346379
2016-12-01

Respiratory syncytial virus vaccine

#2783
20160346355
2016-12-01

Cytokine receptor peptides, compositions thereof and methods thereof

#2784
20160341744
2016-11-24

Pharmaceutical compositions containing peptides derived from human BPLP protein

#2785
20160340392
2016-11-24

Beta sheet tapes ribbons in tissue engineering

#2786
20160333115
2016-11-17

Compounds, compositions and methods for the preparation of peptide/protein conjugates

#2787
20160333105
2016-11-17

Multivalent antibodies

#2788
20160333070
2016-11-17

Pro-angiogenic peptides and peptide conjugates

#2789
20160333052
2016-11-17

Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method

#2790
20160333051
2016-11-17

Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity

#2791
20160333050
2016-11-17

Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method

#2792
20160333049
2016-11-17

Peptidomimetic macrocycles and uses thereof

#2793
20160331805
2016-11-17

Treatment of ocular disorders with anti-connexin proteins and mimetics

#2794
20160331804
2016-11-17

Selectively targeted antimicrobial peptides and the use thereof

#2795
20160331800
2016-11-17

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

#2796
20160326217
2016-11-10

Methods and Compositions Related to Cyclic Peptide Synthesis

#2797
20160326216
2016-11-10

HCV PROTEASE INHIBITORS AND USES THEREOF

#2798
20160324976
2016-11-10

Peptide having cell membrane penetrating activity

#2799
20160324937
2016-11-10

Fragments of P97 and uses thereof

#2800
20160319321
2016-11-03

Enterokinase cleavable polypeptides

#2801
20160319287
2016-11-03

ATYPICAL INTEINS

#2802
20160318975
2016-11-03

Method for promoting expression of calreticulin, and synthetic peptide for use in method for promoting expression of calreticulin

#2803
20160311872
2016-10-27

Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof

#2804
20160311860
2016-10-27

Peptide domains that bind small molecules of industrial significance

#2805
20160311858
2016-10-27

PEPTIDE-COMPOUND CYCLIZATION METHOD

#2806
20160311855
2016-10-27

Growth Hormone Releasing Peptides

#2807
20160311854
2016-10-27

Immune system modulators

#2808
20160310586
2016-10-27

TOPK peptides and vaccines including the same

#2809
20160305952
2016-10-20

Specific peptide binders to proteins identified via systematic discovery, maturation and extension process

#2810
20160304564
2016-10-20

Triazole macrocycle systems

#2811
20160304561
2016-10-20

Glycopeptide compositions and uses thereof

#2812
20160304560
2016-10-20

PAR4 agonist peptides

#2813
20160304559
2016-10-20

PEPTIDE BASED INHIBITION OF caPCNA INTERACTION IN CANCER

#2814
20160304558
2016-10-20

Cationic lipid formulations for regressing established tumor

#2815
20160304554
2016-10-20

Process for the manufacture of cyclic undecapeptides

#2816
20160304459
2016-10-20

NOVEL COMPOUND, PRODUCTION METHOD THEREFOR, AND APPLICATION THEREFOR

#2817
20160303251
2016-10-20

CONJUGATES OF GARFTASE INHIBITORS

#2818
20160298138
2016-10-13

CRISPR-BASED GENOME MODIFICATION AND REGULATION

#2819
20160298137
2016-10-13

CRISPR-BASED GENOME MODIFICATION AND REGULATION

#2820
20160298136
2016-10-13

CRISPR-BASED GENOME MODIFICATION AND REGULATION

#2821
20160298135
2016-10-13

CRISPR-based genome modification and regulation

#2822
20160298134
2016-10-13

CRISPR-based genome modification and regulation

#2823
20160298133
2016-10-13

CRISPR-BASED GENOME MODIFICATION AND REGULATION

#2824
20160298132
2016-10-13

CRISPR-BASED GENOME MODIFICATION AND REGULATION

#2825
20160298125
2016-10-13

CRISPR-BASED GENOME MODIFICATION AND REGULATION

#2826
20160297861
2016-10-13

Interferon Analogs

#2827
20160297858
2016-10-13

Dpy-30 binding peptides and methods of use

#2828
20160297851
2016-10-13

BROAD SPECTRUM ANTIBIOTIC ARYLOMYCIN ANALOGS

#2829
20160296594
2016-10-13

Antimicrobial peptides and methods of use thereof

#2830
20160289668
2016-10-06

Production method for charged non-protein amino acid-containing peptide

#2831
20160289287
2016-10-06

SMALL CATIONIC ANTI-BIOFILM AND IDR PEPTIDES

#2832
20160289274
2016-10-06

Triazole macrocycle systems

#2833
20160289269
2016-10-06

Cell-penetrating compositions and methods using same

#2834
20160287895
2016-10-06

Light-sensitive ion-passing molecules

#2835
20160287663
2016-10-06

Methods of treating cancers with peptide-based modulators

#2836
20160282361
2016-09-29

Mass spectrometric assays for peptides

#2837
20160280760
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2838
20160280759
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2839
20160280758
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2840
20160280757
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2841
20160280753
2016-09-29

Biologically active proteins having increased in vivo and/or in vitro stability

#2842
20160280752
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2843
20160280739
2016-09-29

Modified kisspeptin peptides and uses thereof

#2844
20160280738
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2845
20160280632
2016-09-29

Gamma amino acid building blocks

#2846
20160279257
2016-09-29

Compositions and methods relating to nucleic acid-protein complexes

#2847
20160279217
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2848
20160279214
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#2849
20160274094
2016-09-22

Zwitterionic reagents

#2850
20160272682
2016-09-22

Glycopeptide antibiotic analogs effective against vancomycin-resistant bacterial strains

#2851
20160272679
2016-09-22

WNT FAMILY-DERIVED PEPTIDES AND USE THEREOF

#2852
20160272678
2016-09-22

Inhibition of pulmonary fibrosis with nutlin-3A and peptides

#2853
20160272672
2016-09-22

Photolabile linker for the solid-phase synthesis of hydrazides and pyranopyrazoles

#2854
20160271204
2016-09-22

CEACAM based antibacterial agents

#2855
20160265000
2016-09-15

Engineered cleavage half-domains for generating nuclease-mediated genomic modifications in a cell

#2856
20160264627
2016-09-15

Cyclic peptide binder against oncogenic K-Ras

#2857
20160264626
2016-09-15

Method for producing peptide hydrazide, peptide amide, and peptide thioester

#2858
20160264624
2016-09-15

Tubulysin compounds, methods of making and use

#2859
20160263234
2016-09-15

Prodrugs of peptide epoxy ketone protease inhibitors

#2860
20160262388
2016-09-15

Bioactive peptides having insecticide activity

#2861
20160257721
2016-09-08

Desmoglein 2 (DSG2) binding proteins and uses therefor

#2862
20160257717
2016-09-08

Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivation

#2863
20160257713
2016-09-08

Cell-penetrating peptides

#2864
20160257712
2016-09-08

Integrin interaction inhibitors for the treatment of cancer

#2865
20160257711
2016-09-08

Inhibitors of beta integrin-G protein alpha subunit binding interactions

#2866
20160256560
2016-09-08

Environmentally sensitive compositions and methods of use thereof

#2867
20160256483
2016-09-08

Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof

#2868
20160252523
2016-09-01

Method for removing genomically unstable IPS cells and synthetic peptide used therefor

#2869
20160251402
2016-09-01

MICROPEPTIDES AND USE OF SAME FOR MODULATING GENE EXPRESSION

#2870
20160250325
2016-09-01

Adjuvant compound

#2871
20160250320
2016-09-01

Immunoregulatory peptides and methods of use

#2872
20160250307
2016-09-01

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

#2873
20160250278
2016-09-01

Peptidomimetic macrocycles

#2874
20160244521
2016-08-25

Anti-PVRIG antibodies and methods of use

#2875
20160244508
2016-08-25

Use of endostatin peptides for the treatment of fibrosis

#2876
20160244507
2016-08-25

Peptide compounds for suppressing inflammation

#2877
20160244486
2016-08-25

AB Modulating Peptides

#2878
20160243252
2016-08-25

Compounds containing a vascular disrupting agent

#2879
20160243210
2016-08-25

Methods and compositions based on Shiga toxin type 2 protein

#2880
20160237421
2016-08-18

Enzyme substrate comprising a functional dye and associated technology and methods

#2881
20160237118
2016-08-18

Leukemia stem cell targeting ligands and methods of use

#2882
20160237117
2016-08-18

Connective tissue stimulating peptides

#2883
20160235806
2016-08-18

Peptide compound for inhibiting restenosis and promoting re-endothelialization and method for preparing the same

#2884
20160229893
2016-08-11

Novel Peptide Compound for Inhibiting Restenosis and Promoting Re-Endothelialization and Method for Preparing the Same

#2885
20160229892
2016-08-11

Cyclic peptide conjugates and methods of use

#2886
20160229891
2016-08-11

SALT OF POLYPEPTIDE VACCINE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL PREPARATION COMPRISING SAID SALT

#2887
20160229890
2016-08-11

Peptides and analogs for use in the treatment of oral mucositis

#2888
20160228621
2016-08-11

Peptide compound for inhibiting restenosis and promoting re-endothelialization and method for preparing the same

#2889
20160228546
2016-08-11

Anti-EGFR activatable antibodies

#2890
20160228522
2016-08-11

Oligomer-specific amyloid beta epitope and antibodies

#2891
20160228493
2016-08-11

Aminostatin derivatives for the treatment of arthrosis

#2892
20160228488
2016-08-11

NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING

#2893
20160228470
2016-08-11

Composition comprising neural cell and elastin-like polypeptide for treating Parkinson's disease

#2894
20160222430
2016-08-04

D-ALA-D-ALA-BASED DIPEPTIDES AS TOOLS FOR IMAGING PEPTIDOGLYCAN BIOSYNTHESIS

#2895
20160222084
2016-08-04

Compositions Comprising D-Amino Acid Peptides and Methods of Production and Use Thereof for Inhibiting Autoantibodies

#2896
20160222078
2016-08-04

VIP fragments and methods of use

#2897
20160222059
2016-08-04

Method for preparing eptifibatide

#2898
20160220632
2016-08-04

Angiotensin type 2 (AT2) receptor agonists and uses thereof

#2899
20160219880
2016-08-04

Peptoid oligomers, pharmaceutical compositions and methods of using the same

#2900
20160215019
2016-07-28

Peptides capable of reactivating p53 mutants

#2901
20160215018
2016-07-28

Pharmaceutical composition for preventing or treating ocular surface disease

#2902
20160215017
2016-07-28

Brachiatin D and process for production thereof

#2903
20160209421
2016-07-21

Macrocyclic peptide, method for producing same, and screening method using macrocyclic peptide library

#2904
20160209412
2016-07-21

MSIA-SRM ASSAY FOR BIOMARKER ANALYSIS

#2905
20160207960
2016-07-21

Peptides inhibiting cold-inducible RNA binding protein activity

#2906
20160207959
2016-07-21

Methods and compositions for treatment of cartilage and disc tissue pathologies

#2907
20160206736
2016-07-21

Ligands to radiation-induced molecules

#2908
20160206566
2016-07-21

Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)

#2909
20160200770
2016-07-14

Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase

#2910
20160200765
2016-07-14

Modified mini-hepcidin peptides and methods of using thereof

#2911
20160200764
2016-07-14

PEPTIDE VACCINES FOR CANCERS EXPRESSING TUMOR-ASSOCIATED ANTIGENS

#2912
20160200763
2016-07-14

Glycogen synthase kinase-3 inhibitors

#2913
20160199505
2016-07-14

Peptides and peptide/active compound conjugates for renal targeting

#2914
20160199504
2016-07-14

Development of novel macromolecule transduction domain with improved cell permeability and method for using same

#2915
20160199498
2016-07-14

Peptides for enhancing transdermal delivery

#2916
20160194358
2016-07-07

LINEAR PEPTIDE ANTIBIOTCS

#2917
20160194357
2016-07-07

NPR-B agonists

#2918
20160193581
2016-07-07

Mineralizing biosurfactant used for nucleating silica

#2919
20160193355
2016-07-07

Novel linker, preparation method, and application thereof

#2920
20160193315
2016-07-07

PEPTIDES SHARED AMONG LETHAL CANCERS AND THERAPEUTIC COMPOSITIONS COMPRISING SAID PEPTIDES

#2921
20160193279
2016-07-07

Methods and compositions for the treatment of axonal and neuronal degeneration

#2922
20160185821
2016-06-30

Z-SELECTIVE OLEFIN METATHESIS OF PEPTIDES

#2923
20160185819
2016-06-30

Peptides for the stimulation of collagen formation

#2924
20160185818
2016-06-30

Bidentate-binding modulators of LRRK2 and JNK kinases

#2925
20160184447
2016-06-30

Car peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disorders

#2926
20160184385
2016-06-30

Peptide having ability to synthesize collagen and use thereof

#2927
20160184345
2016-06-30

Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof

#2928
20160178627
2016-06-23

System and method for identification and characterization of transglutaminase species

#2929
20160176925
2016-06-23

Melanocortin receptor ligands modified with hydantoin

#2930
20160176924
2016-06-23

Modified peptides as potent inhibitors of the PSD-95/NMDA receptor interaction

#2931
20160176923
2016-06-23

NONAPEPTIDE WITH ANTI-TUMOUR ACTIVITY

#2932
20160176918
2016-06-23

Coupling method for peptide synthesis at elevated temperatures

#2933
20160175405
2016-06-23

Fusion proteins and methods for treating HIV infection and AIDS related symptoms

#2934
20160175399
2016-06-23

IL-13 receptor binding peptides

#2935
20160175226
2016-06-23

Stabilized calcium phosphate complexes

#2936
20160169885
2016-06-16

Detection of degradative enzymes and biomolecules in bodily fluids

#2937
20160168200
2016-06-16

IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC

#2938
20160168197
2016-06-16

Method for cancer immunotherapy

#2939
20160166680
2016-06-16

CD200 inhibitors and methods of use thereof

#2940
20160165916
2016-06-16

Peptides and their use in food and beverage

#2941
20160161482
2016-06-09

Means and methods for diagnosing and treating multiple sclerosis

#2942
20160159863
2016-06-09

Antibody targeting through a modular recognition domain

#2943
20160159862
2016-06-09

A4B7 peptide monomer and dimer antagonists

#2944
20160159861
2016-06-09

APJ Receptor Compounds

#2945
20160159860
2016-06-09

Therapeutic agents for reducing parathyroid hormone levels

#2946
20160159859
2016-06-09

Protease-resistant peptide ligands

#2947
20160158312
2016-06-09

Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

#2948
20160153997
2016-06-02

OLIGOPEPTIDE SPECIFIC TO COLORECTAL CANCER CELL AND APPLICATION THEREOF

#2949
20160152665
2016-06-02

Compositions and methods of treatment of cancers

#2950
20160152664
2016-06-02

α4β7 peptide monomer and dimer antagonists

#2951
20160151534
2016-06-02

Anti-microbial peptides and methods of use thereof

#2952
20160151470
2016-06-02

Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteins

#2953
20160145605
2016-05-26

PEPTIDE-PRESENTING PROTEIN AND PEPTIDE LIBRARY USING SAME

#2954
20160145309
2016-05-26

Disulfide cyclic polypeptides for the treatment of heart failure

#2955
20160145306
2016-05-26

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

#2956
20160145305
2016-05-26

Energy transfer within pi-conjugated peptide heterostructures in aqueous environments

#2957
20160145304
2016-05-26

CYSTOBACTAMIDES

#2958
20160145303
2016-05-26

Strong Secretory Signal Peptide Enhancing Small Peptide Motifs and the Use Thereof

#2959
20160145302
2016-05-26

Short peptide targeting EPS8 binding with EGFR and use thereof

#2960
20160145301
2016-05-26

Process for the manufacture of degarelix and its intermediates

#2961
20160145300
2016-05-26

ARTIFICIAL DECAPEPTIDE, MEDICATION AND METHOD OF INDUCING BREEDING OF CRUSTACEANS

#2962
20160145299
2016-05-26

Cell penetrating peptides for intracellular delivery of molecules

#2963
20160138078
2016-05-19

Modulators for SIRT6 and assays for screening same

#2964
20160137689
2016-05-19

PEPTIDE-RESIN CONJUGATE AND USE THEREOF

#2965
20160132631
2016-05-12

BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING

#2966
20160130311
2016-05-12

T CELL EPITOPES DERIVED FROM ALT A 1 OR ALT A 5 FOR THE TREATMENT OF ALTERNARIA ALTERNATA ALLERGY

#2967
20160130302
2016-05-12

Compositions and methods for specific regulation of pyruvate dehydrogenase kinase

#2968
20160130301
2016-05-12

Peptide and uses thereof

#2969
20160122415
2016-05-05

Methods and compositions for the treatment of cancer

#2970
20160122397
2016-05-05

REPLIKIN-BASED COMPOUNDS FOR PREVENTION AND TREATMENT OF INFLUENZA AND METHODS OF DIFFERENTIATING INFECTIVITY AND LETHALITY IN INFLUENZA

#2971
20160122389
2016-05-05

Peptides with antagonistic activities against natural CXCR4

#2972
20160122387
2016-05-05

Angiotensin Peptide and Pharmaceutical Compositions for Disease Treatment

#2973
20160122386
2016-05-05

V1A receptor agonists

#2974
20160120998
2016-05-05

Cell-penetrating drug carrier and the application thereof

#2975
20160120933
2016-05-05

Inhibitors of mitochondrial fission and methods of use thereof

#2976
20160116469
2016-04-28

Immunologically active polypeptide

#2977
20160115200
2016-04-28

New Use for JNK Inhibitor Molecules for Treatment of Various Diseases

#2978
20160115199
2016-04-28

Cell penetrating peptides for intracellular delivery of molecules

#2979
20160115196
2016-04-28

SELF-ASSEMBLED MICRO-AND NANOSTRUCTURES

#2980
20160113853
2016-04-28

Oleanoyl peptide composition and skin hydration

#2981
20160108444
2016-04-21

Strain having enhanced L-valine productivity and L-valine production method using the same

#2982
20160108088
2016-04-21

Anti-angiogenic molecules, nanostructures and uses thereof

#2983
20160108087
2016-04-21

Therapeutics for the induction of endogenous steroidogenesis and methods associated with their identification

#2984
20160108086
2016-04-21

Peptide stimulator of cell survival and proliferation

#2985
20160103108
2016-04-14

Peptide selectively binding to volatile organic compounds

#2986
20160102121
2016-04-14

Peptide Inhibitors of Sodium Channels

#2987
20160101171
2016-04-14

MELK epitope peptides and vaccines containing the same

#2988
20160101150
2016-04-14

Peptides having anti-inflammatory properties

#2989
20160101032
2016-04-14

Peptide with anti-aging effect and use thereof

#2990
20160089414
2016-03-31

Inhibitors of NOX1

#2991
20160084860
2016-03-24

Multifunctional protein molecular weight ladders

#2992
20160084829
2016-03-24

Self-assembled peptide nanostructures by exploiting conformational change, biosensor using the same and detection method of biomolecules using the same

#2993
20160083429
2016-03-24

COMPOSITIONS AND METHODS FOR ENDOTOXIN NEUTRALIZATION

#2994
20160083428
2016-03-24

Inhibitors of the Eph-A receptor and uses thereof

#2995
20160083426
2016-03-24

Non-benzenoid aromatic systems for imaging, monitoring and therapy

#2996
20160083425
2016-03-24

Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels

#2997
20160083424
2016-03-24

COMPOSITIONS AND METHODS FOR TARGETING ANTIGEN-PRESENTING CELLS

#2998
20160081903
2016-03-24

Method for promoting hair growth

#2999
20160075748
2016-03-17

Aquaporin-4 Peptide Compositions and Methods of Use

#3000
20160075738
2016-03-17

Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions